BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Australia

Cynata Enters into a New Strategic Partnership with Fujifilm

Cynata Therapeutics Limited (ASX: "CYP" or "Cynata"), a clinical-stage biotechnology company specialising in cell therapeutics, has today an...

October 01, 2021 | News

Zantrene® kills melanoma cancer cells that overproduce FTO

Zantrene® at low concentrations kills high FTO producing melanoma cancer cells Sensitivity to Zantrene® correlates with FTO levels, where high F...

September 30, 2021 | News

Biocytogen announces collaboration with Envigo

Biocytogen announces a collaboration with Envigo, a global organization that offers the widest range of research models and related services. The two compa...

September 29, 2021 | News

Agilex Biolabs Announced as Citeline Award Finalist for COVID-19 Vaccine Toxicology Preclinical Research

The Citeline Awards were created to recognize accomplishments across the biopharmaceutical industry, providing an opportunity for the industry to honor its...

September 24, 2021 | News

Bionomics Prepares BNC210 for Start of Phase 2 Acute Treatment of Social Anxiety Disorder Trial

Rapid oral absorption of BNC210 novel tablet formulation potentially well-suited for acute treatment of anxiety in patients with Social Anxiety D...

September 21, 2021 | News

Illumina reaffirms commitment to the National Project of Bio Big Data in Korea

The multi-ministerial project is overseen by the Ministry of Health and Welfare, Ministry of Trade and Industry, Ministry of Science and ICT, and Korea Dis...

September 20, 2021 | News

Allianz Partners expands its Digital Health Assistant to ten markets in Asia-Pacific

Initially launched in Europe, this new service gives customers access to a range of digital health services and medical professionals This digital ...

September 16, 2021 | News

Australia Approved New Therapy to Treat Advanced Small Cell Lung Cancer

Highlights: ZEPZELCA® (lurbinectedin) is the first new therapy approved to treat second-line metastatic SCLC in Australia in more tha...

September 15, 2021 | News

HaemaLogiX raises $10 million to advance multiple myeloma treatments

HaemaLogiX completes a fully subscribed $10 million share placement and welcomes Platinum Asset Management as core new institutional investor w...

September 09, 2021 | News

Odyssey Group Approved to Start Human Trial to Treat Concussion

The Company’s Clinical Trial Protocol was approved by the Alfred Ethics Committee and allows for the immediate start of the human trial. “We a...

September 08, 2021 | News

Study Confirms Viraleze Provides Protection Against SARS-CoV-2

The findings, published in the peer-reviewed journal Viruses, in a special issue titled Medical Interventions for Treatment and Prevention of SAR...

August 24, 2021 | News

BioAgilytix to Purchase Australia-based 360biolabs®

BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused on supporting its pharmaceutical and biotech partners in all sta...

August 17, 2021 | News

Strengthening Australia’s regenerative medicine value chain

The Australian biotech sector is actively considering how it can support greater access to ground-breaking therapies for Australians, as RM challenges the ...

August 13, 2021 | News

Diabetes treatment lowers PromarkerD risk score for diabetic kidney disease

In a study presented at the Australasian Diabetes Congress today, researchers used PromarkerD, the world's first predictive diagnostic test for diabetic ki...

August 13, 2021 | News

Stay Connected